Somatostatin receptor scintigraphy with In-111-[DTPA-D-Phe(1)]-octreotide h
as the potential for visualizing primary and recurrent thymomas in patients
with myasthenia gravis, whereas thymic hyperplasias fail to accumulate som
atostatin analog peptides. We demonstrate somatostatin receptor imaging fin
dings in a patient with a mixed encapsulated thymoma which exhibited intens
e In-111-[DTPA-D-Phe(1)] -octreotide uptake in early and late scans. In ano
ther patient with a history of malignant thymoma In-111-[DTPA-D-Phe(1)] -oc
treotide accumulation was clearly seen in a mass suspected to be a recurren
ce. This paper describes the imaging protocol including Single Photon Emiss
ion Computed Tomography (SPECT) and discusses the clinical applications of
this feasible functional imaging method in patients with thymomas.